Changes in Arterial Stiffness but Not Carotid Intimal Thickness in Acromegaly
Overview
Authors
Affiliations
Context: Acromegaly increases cardiovascular morbidity. We tested the hypothesis that increased arterial stiffness together with left ventricular hypertrophy may be a contributory factor.
Patients And Design: Fifty-six patients (40 males, 54 ± 13 yr; 25 active disease, 31 in remission) and 46 healthy controls (30 males, 52 ± 13 yr) underwent measurements of aortic pulse wave velocity (PWV), carotid Doppler (IMT), echocardiography, and cardiovascular risk factors.
Results: Mean serum IGF-I was 323 ± 286 ng/ml (sd score 1.8 ± 1.9) in all patients. Age, body mass index, diastolic blood pressure (BP), and lipid levels were similar comparing patients and controls. Systolic BP (130.8 ± 19.9 vs. 122 ± 14 mm Hg controls, P < 0.01) and PWV (11.7 ± 3.8 vs. 9.7 ± 2.8 m/sec, 95% confidence interval -3.4 to -0.7, P <0.01) were higher in patients than controls. Regression analysis revealed age, presence of acromegaly, systolic BP, and body mass index, inversely, as significantly and independently associated with PWV. No difference in carotid IMT was seen (0.8 ± 0.2 patients vs. 0.7 ± 0.2 mm controls, P = 0.5) or between active/controlled disease. In the subset of participants with echocardiography (n = 32), left ventricular mass was higher by a mean of 38.2 g (95% confidence interval -80.9 to +4.6, P = 0.08).
Conclusion: In summary, patients with acromegaly had independently and significantly increased aortic PWV as evidence of arterial stiffening but unaltered carotid IMT compared with controls, also influenced by age and systolic BP. Premature cardiovascular disease in patients with acromegaly is likely related to pressure-related arterial and left ventricular stiffening rather than atherosclerotic disease.
Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat?.
Rivera F, Talino M, Ansay M, Mangubat G, Mahilum M, Menghrajani R Rev Cardiovasc Med. 2024; 24(4):95.
PMID: 39076279 PMC: 11273026. DOI: 10.31083/j.rcm2404095.
Myocardial, Valvular, and Vascular Structural and Functional Properties in Acromegaly.
Nemes A, Kormanyos A, Ambrus N, Lengyel C, Valkusz Z J Clin Med. 2023; 12(21).
PMID: 37959322 PMC: 10648583. DOI: 10.3390/jcm12216857.
Evaluation of Peripapillary Microcirculation in Patients with Acromegaly.
Karahan M, Armagan Demirtas A, Hazar L, Ava S, Pekkolay Z, Keklikci U Beyoglu Eye J. 2022; 6(4):285-289.
PMID: 35059575 PMC: 8759556. DOI: 10.14744/bej.2021.48343.
Acromegaly, inflammation and cardiovascular disease: a review.
Wolters T, Netea M, Riksen N, Hermus A, Netea-Maier R Rev Endocr Metab Disord. 2020; 21(4):547-568.
PMID: 32458292 PMC: 7560935. DOI: 10.1007/s11154-020-09560-x.
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide.
Puglisi S, Ferrau F, Ragonese M, Spagnolo F, Cannavo S Front Endocrinol (Lausanne). 2020; 11:28.
PMID: 32117056 PMC: 7017075. DOI: 10.3389/fendo.2020.00028.